Healthcare
Piramal Pharma Limited (PPLPHARMA)
Piramal Pharma Limited (PPLPHARMA) is an NSE-listed Healthcare company. latest close ₹213.67, 1-day return -1.4%, 1-week return +3.4%. This page shows price, returns, and technical signals from QUANTSCASE. Informational only — not investment advice.
Data as of 20 Aug 2026
For informational and educational purposes only. Not investment advice. QUANTSCASE is a stock screener, not a SEBI-registered investment adviser, research analyst, or portfolio manager. Terms
Price & returns
- Last close
- ₹213.67
- 1-day return
- -1.4%
- 1-week return
- +3.4%
- 1-month return
- +20.6%
Technical signals
Latest daily indicators. These are screen readings, not buy or sell calls.
- RSI (14)
- 61.4
- ADX (14)
- 22.1
- ROC 10
- +2.0%
- vs 52W high
- -3.0%
Fundamentals snapshot
Latest fields from our NSE fundamentals table. Figures can lag the live tape.
- Market cap
- ₹28,312 Cr
- P/E
- —
- P/B
- 3.47
- ROE
- —
- D/E
- 69.98
- Net margin
- -3.4%
- Rev. growth YoY
- -17.6%
- Div. yield
- 8.0%
- 52W high
- ₹220.4
- 52W low
- ₹132.3
- EPS (TTM)
- ₹-2.38
Live signals
Built from the latest price, 1-day / 1-week return, and technical snapshot — not a news calendar.
- signal
1-day return -1.4%
Latest 1-day price change versus the previous close.
- signal
1-week return +3.4%
Price change over the last five trading sessions.
- signal
EMA stack is aligned up
Short EMAs are stacked above longer EMAs on the daily chart.
- signal
Within 3.0% of the 52-week high
Price is near the 52-week high on the latest technicals snapshot.
News & screener mentions
Recent QUANTSCASE daily posts that listed PPLPHARMA.
No recent screener posts mentioned PPLPHARMA yet. New daily posts will show up here automatically.
